Ling‐Wei Hsin

1.1k total citations
47 papers, 827 citations indexed

About

Ling‐Wei Hsin is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ling‐Wei Hsin has authored 47 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Organic Chemistry and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ling‐Wei Hsin's work include Chemical synthesis and alkaloids (9 papers), Cancer therapeutics and mechanisms (6 papers) and Neuroscience and Neuropharmacology Research (6 papers). Ling‐Wei Hsin is often cited by papers focused on Chemical synthesis and alkaloids (9 papers), Cancer therapeutics and mechanisms (6 papers) and Neuroscience and Neuropharmacology Research (6 papers). Ling‐Wei Hsin collaborates with scholars based in Taiwan and United States. Ling‐Wei Hsin's co-authors include Kenner C. Rice, Ji‐Wang Chern, Chao‐Wu Yu, Christina M. Dersch, Richard B. Rothman, Emily M. Jutkiewicz, David Stafford, James H. Woods, Susan K. Wood and John R. Glowa and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Ling‐Wei Hsin

45 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ling‐Wei Hsin Taiwan	16	409	255	143	121	114	47	827
Suzhen Dong China	18	437 1.1×	261 1.0×	166 1.2×	54 0.4×	34 0.3×	53	1.1k
Chafiq Hamdouchi Spain	17	238 0.6×	751 2.9×	201 1.4×	42 0.3×	102 0.9×	39	1.2k
Jeffrey P. Whitten United States	21	918 2.2×	496 1.9×	204 1.4×	95 0.8×	168 1.5×	45	1.8k
Andrew W. Stamford United States	22	604 1.5×	479 1.9×	245 1.7×	92 0.8×	24 0.2×	51	1.5k
R. Pellicciari Italy	17	341 0.8×	155 0.6×	160 1.1×	280 2.3×	249 2.2×	43	1.1k
Sandrine Desrayaud Switzerland	19	485 1.2×	157 0.6×	339 2.4×	110 0.9×	29 0.3×	38	1.1k
Vladimı́r Pouzar Czechia	16	412 1.0×	179 0.7×	116 0.8×	33 0.3×	88 0.8×	115	837
Kenneth L. Hauser United States	7	239 0.6×	149 0.6×	212 1.5×	43 0.4×	24 0.2×	9	594
David J. Wustrow United States	20	746 1.8×	611 2.4×	491 3.4×	207 1.7×	35 0.3×	54	1.7k
Monika Głuch‐Lutwin Poland	19	425 1.0×	299 1.2×	224 1.6×	65 0.5×	30 0.3×	74	945

Countries citing papers authored by Ling‐Wei Hsin

Since Specialization

Citations

This map shows the geographic impact of Ling‐Wei Hsin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Wei Hsin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Wei Hsin more than expected).

Fields of papers citing papers by Ling‐Wei Hsin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Wei Hsin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Wei Hsin. The network helps show where Ling‐Wei Hsin may publish in the future.

Co-authorship network of co-authors of Ling‐Wei Hsin

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐Wei Hsin. A scholar is included among the top collaborators of Ling‐Wei Hsin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐Wei Hsin. Ling‐Wei Hsin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Sung‐Bau, Kai‐Cheng Hsu, Ling‐Wei Hsin, et al.. (2023). Synthesis and biological evaluation of C-4 substituted phenoxazine-bearing hydroxamic acids with potent class II histone deacetylase inhibitory activities. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2212326–2212326. 4 indexed citations

Yang, Yi-Ting, Chia‐Hung Tu, Tsung‐Chun Lee, et al.. (2022). 5-HT7 receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome. Laboratory Investigation. 102(9). 1023–1037. 17 indexed citations

Li, Yu‐Hsuan, Chao‐Wu Yu, Jui‐Ling Hsu, et al.. (2021). Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity. Bioorganic Chemistry. 110. 104813–104813. 5 indexed citations

Hsu, Kai‐Cheng, Hao‐Ching Wang, Tony Eight Lin, et al.. (2021). Synthesis and biological evaluation of phenothiazine derivative-containing hydroxamic acids as potent class II histone deacetylase inhibitors. European Journal of Medicinal Chemistry. 219. 113419–113419. 13 indexed citations

Huang, Ya-Yao, Chia‐Ying Yang, Mei‐Fang Cheng, et al.. (2020). Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[18F]fluoropropyl)-L-glutamic acid ([18F]FSPG) for clinical use. PLoS ONE. 15(12). e0243831–e0243831. 4 indexed citations

Cheng, Mei‐Fang, Ya-Yao Huang, Bing‐Ying Ho, et al.. (2019). Prospective comparison of (4S)-4-(3-18F-fluoropropyl)-l-glutamate versus 18F-fluorodeoxyglucose PET/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of-concept study. European Journal of Nuclear Medicine and Molecular Imaging. 46(4). 810–820. 16 indexed citations

Huang, Ya-Yao, Ming‐Jang Chiu, Ruoh‐Fang Yen, et al.. (2019). An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans. PLoS ONE. 14(7). e0217384–e0217384. 5 indexed citations

Yu, Chao‐Wu, et al.. (2019). High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma. Biochemical Pharmacology. 163. 458–471. 70 indexed citations

Chuang, Hsiao-Ching, et al.. (2017). Targeting breast cancer stem cells by novel HDAC3-selective inhibitors. European Journal of Medicinal Chemistry. 140. 42–51. 60 indexed citations

10.

Lin, Chuan‐Chuan, et al.. (2014). Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers. Cellular and Molecular Life Sciences. 72(9). 1825–1837. 11 indexed citations

11.

Hsin, Ling‐Wei, et al.. (2014). Activation of serotonin 5-HT7 receptor induces coronary flow increase in isolated rat heart. European Journal of Pharmacology. 748. 68–75. 12 indexed citations

12.

Hsin, Ling‐Wei, Hsiang-Chin Chen, Wanru Chen, et al.. (2012). Anthracenedione–methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles. Biochemical Pharmacology. 83(9). 1208–1216. 11 indexed citations

13.

Xu, Heng, Christina M. Dersch, Ling‐Wei Hsin, et al.. (2009). Identification of a novel “almost neutral” μ‐opioid receptor antagonist in CHO cells expressing the cloned human μ‐opioid receptor. Synapse. 64(4). 280–288. 23 indexed citations

14.

Hsiao, Che‐Jen, Tsai‐Kun Li, Ling‐Wei Hsin, et al.. (2007). WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: Identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers. Biochemical Pharmacology. 75(4). 847–856. 34 indexed citations

15.

Hsin, Ling‐Wei, Hui‐Po Wang, Wanru Chen, et al.. (2007). Synthesis, DNA binding, and cytotoxicity of 1,4-bis(2-amino-ethylamino)anthraquinone–amino acid conjugates. Bioorganic & Medicinal Chemistry. 16(2). 1006–1014. 38 indexed citations

16.

Hsin, Ling‐Wei, Thomas E. Prisinzano, Christina M. Dersch, et al.. (2003). Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents. Bioorganic & Medicinal Chemistry Letters. 13(3). 553–556. 11 indexed citations

17.

Hsin, Ling‐Wei, Xinrong Tian, Elizabeth Webster, et al.. (2002). CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists. Bioorganic & Medicinal Chemistry. 10(1). 175–183. 32 indexed citations

18.

Tian, Xinrong, Ling‐Wei Hsin, Elizabeth Webster, et al.. (2001). The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type 1. Bioorganic & Medicinal Chemistry Letters. 11(3). 331–333. 15 indexed citations

19.

Hsin, Ling‐Wei, et al.. (1994). Synthesis and Opioid Activity of 7-Oxygenated 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolinols. Journal of Medicinal Chemistry. 37(19). 3121–3127. 10 indexed citations

20.

Cheng, Chen, Sarah J. Wu, Ling‐Wei Hsin, & S. William Tam. (1992). Selective reversible and irreversible ligands for the .kappa. opioid receptor. Journal of Medicinal Chemistry. 35(12). 2243–2247. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact